Quality of life measured in first-line therapy during the Cryo-FIRST study: a comparison between cryoballoon catheter ablation versus antiarrhythmic drug therapy

G. B. Chierchia , N. Pavlovic , V. Velagic , Jean-Sylvain Hermida (1, 2) , S. Healy , G. Arena , N. Badenco , C. Meyer (3, 4) , J. Chen (5) , S. Iacopino , F. Anselme (6) , M. Kuniss

1 CHU Amiens-Picardie
2 MP3CV - Mécanismes physiopathologiques et conséquences des calcifications vasculaires - UR UPJV 7517
3 Service de chirurgie maxillo-faciale, stomatologie et odontologie hospitalière [CHRU Besançon]
4 NIT / NANOMEDECINE - Nanomédecine, imagerie, thérapeutique - UFC (UR 4662)
5 McMaster University [Hamilton, Ontario]
6 Service de Cardiologie [CHU Rouen]

Domaines: Sciences du Vivant [q-bio]

G. B. Chierchia, N. Pavlovic, V. Velagic, Jean-Sylvain Hermida, S. Healy, et al.. Quality of life measured in first-line therapy during the Cryo-FIRST study: a comparison between cryoballoon catheter ablation versus antiarrhythmic drug therapy. European Heart Journal, 2020, 41 (2), pp.436. ⟨hal-03572223⟩